Interventional radiology in oncology

Cancer Treatment and Research

Volumn 143, Issue , 2008, Pages 493-511

  O'Connor O J ^a   Buckley, J M ^a   Maher, M M ^a  

^a Department of Medicine National University of Ireland Cork   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTIFICIAL EMBOLISM; BIOPSY; CENTRAL VENOUS CATHETERIZATION; CHOLESTASIS; DIAGNOSTIC IMAGING; FEMALE; HUMAN; KIDNEY; MALE; METHODOLOGY; MIDDLE AGED; NEOPLASM; ONCOLOGY; PATHOLOGY; RADIOLOGY; REVIEW;

ADULT; AGED; BIOPSY; CATHETERIZATION, CENTRAL VENOUS; CHOLESTASIS; DIAGNOSTIC IMAGING; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; KIDNEY; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; NEOPLASMS; RADIOLOGY;

MLCS; MLOWN;

EID: 48249136117     PISSN: 09273042     EISSN: 25098497     Source Type: Book Series    
DOI: 10.1007/978-0-387-75587-8_19     Document Type: Article

References (70)

1. Leyden OO, Under infectious pneumonic Dtsch Med Wochenschr 1883; 9: 52.
2. Cardella JF, Bakal CW, Bertino RE, Burke DR, Drooz A, Haskal AZ at al, for the Society of Interventional Radiology Standards of Practice Committee. Quality improvement guidelines for image-guided percutaneous biopsy in adults. J Vasc Interv Radiol 2003; 14: S227-S230.
3. Arellano RS, Maher MM, Gervais DA, Hahn PF, Mueller PR. The difficult biopsy: Let's make it easier. Curr Probl Diagn Radiol 2003; 32:218-226.
4. Elliott TS, Faroqui MS, Armstrong RF and Hanson GC, Guidelines for good practice in central venous catheterization. Hospital Infection Society and the Research Unit of the Royal College of Physicians. J Hosp Infect 1994; 28: 163-176.
5. Tan PL, Gibson M. Central venous catheters: The role of radiology. Clin Radiol 2006; 61(1): 13-22.
6. Hind D, Calvert C, McWilliams R, et al., Ultrasonic locating devices for central venous can-nulation: Meta-analysis, BMJ 2003; 327: 361-367.
7. Trerotola SO, Kuhn-Fulton J, Johnson MS et al. Tunneled infusion catheters: Increased incidence of symptomatic venous thrombosis after subclavian versus internal jugular venous access, Radiology 2000; 217: 89-93.
8. Lewis CA, Allen TE, Burke DR, Cardella JF, Citron SJ, Cole PE et al, for the Society of Interventional Radiology Standards of Practice Committee. Quality improvement guidelines for central venous access. J Vasc Interv Radiol 2003; 14: S231-S235.
9. Hoch JR. Management of the complications of long-term venous access. Semin Vasc Surg 1997; 10: 135-143.
10. Timsit JF, Farkas JC and Boyer JM et al. Central vein catheter-related thrombosis in intensive care patients: Incidence, risks factors, and relationship with catheter-related sepsis, Chest 1998; 114: 207-213.
11. Tan P, Gibson M. Central venous catheters: The role of Radiology. Clinical Radiology 2006; 61(1): 13-22.
12. Pruemer J. Prevalence, causes, and impact of cancer-associated thrombosis. Am J Health Syst Pharm 2005; 62 (22 Suppl 5): S4-6.
13. Linenberger ML. Catheter-related thrombosis: Risks, diagnosis, and management. J Natl Compr Canc Netw 2006; 4(9): 889-901.
14. Stiges-Serra A. Strategies for prevention of catheter-related bloodstream infections. Support Care Cancer 1999; 7: 391-395.
15. Standards, options et recommandations pour la prévention, le diagnostic et le traitement des infections liées aux voies veineuses en cancérologie. In: FNCLCC, editor. SOR 8: Infection et Cancer, John Libbey, France; 129-179.
16. Dyon D, Mouzon A, Jourde AN, Regensberg C, Frileux C. Hepatic, arterial embolization in patients with malignant liver tumours. Ann Radiol 1974;17:593-603.
17. Brown DB, Cardella JF, Dacks D, Goldberg SN, Gervais DA, Rajan D. et al. for the Society of Interventional Radiology Standards of Practice Committee. Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol 2006; 17: 225-232.
18. Sigurdson ER, Ridge JA, Kemeny N, Daly JM. Tumor and liver drug uptake following hepatic artery and portal vein infusion. J Clin Oncol 1987; 5(11): 1836-40.
19. J Bruix and JM Llovet, Prognostic prediction and treatment strategy in hepatocellular carcinoma, Hepatology 2002; 35: 519-524.
20. Bronowicki JP, Vetter D, Dumas F, Boudjema K, Bader R, Weiss AM, et al. Transcatheter oily chemoembolization of hepatocellular carcinoma. A 4-year study of 127 French patients. Cancer 1994; 197: 101-8.
21. Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J et al.. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial. The Lancet 2002; 359(9319): 1734-1739
22. Gupta S, Yao JC, Ahrar K, et al. Hepatic artery embolisation and chemoembolisation for treatment of patients with metastatic carcinoid tumours: The M.D. Anderson experience. Cancer J 2003; 9: 261-267.
23. Soulen MC. A randomized phase 3 study of systemic chemotherapy with or without hepatic chemoembolisation for liver-dominant metastatic adenocarcinoma of the colon and rectum. ACRIN protocol: 6655(www.acrin.org).
24. Reed RA, Teitelbaum GP, Daniels JR, et al. Prevalence of infection following hepatic chemoembolisation with cross linked collagen with administration of prophylactic antibiotics. J Vasc Interv Radiol 1994; 5: 367-371.
25. Nijsen JF, van Het Schip AD, Hennick WE, Rook DW, Rijk PP, de Klerk JM. Advances in nuclear oncology: Microspheres for internal radionuclidetherapy of liver tumours. Current Medicinal Chemistry 2002; 9: 73-82.
26. Salem R, Thurston KG. Radioembolization with yttrium-90 microspheres: A state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: Part 3: Comprehensive literature review and future direction. J Vasc Interv Radiol 2006; 17(10): 1571-93.
27. Goldberg SN, Dupuy DE. Image-guided radiofrequency tumour ablation: Challenges and opportunities-part 1. J Vasc Interv Radiol 2001; 12: 1021-1032.
28. Kettenbach J, Kostler W, Rucklinger E at al. Percutaneous saline-enhanced radiofrequency ablation of unresectable liver tumours: Initial experience in 26 patients. AJR 2003; 180: 1537-1545.
29. Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumours with percutaneous radiofrequency ablation: Complications encountered in a multidisciplinary study. Radiology 2003; 226: 441-51.
30. de Meijer VE, Verhoef C, Kuiper JW, Alwayn IP, Kazemier G, Ijzermans JN. Radiofrequency ablation in patients with primary and secondary hepatic malignancies. J Gastrointest Surg 2006; 10(7): 960-73.
31. Rose SC, Thistlethwaite PA, Sewell PE, Vance RB. Lung cancer and radiofrequency ablation. J Vasc Interv Radiol 2006; 17(6): 927-51.
32. Brown DB. Concepts, considerations, and concerns on the cutting edge of radiofrequency ablation. J Vasc Interv Radiol 2005; 16(5): 597-613.
33. Goldberg SN, Grassi CJ, Cardella JF, Charboneau JW, Dodd GD 3rd, Dupuy DE, Gervais D, Gillams AR, Kane RA, Lee FT Jr, Livraghi T, McGahan J, Phillips DA, Rhim H, Silverman SG; Society of Interventional Radiology Technology Assessment Committee; International Working Group on Image-Guided Tumor Ablation. Image-guided tumor ablation: Standardization of terminology and reporting criteria. Radiology 2005; 235(3): 728-39.
34. Dupuy DE, Goldberg SN. Image-guided radiofrequency tumor ablation: Challenges and opportunities-part2. J Vasc Interv Radiol 2001; 12: 1135-1148.
35. Shiba H, Okamoto T, Futagawa Y, Ohashi T, Eto Y. Efficient and cancer-selective gene transfer to hepatocellular carcinoma in a rat using adenovirus vector with iodized oil esters. Cancer Gene Ther 2001; 8: 713-718.
36. Gerolami R, Cardoso J, Bralet MP, Cuenod CA, Clement O, Tran PL, Brechot C. Enhanced in vivo adenovirus-mediated gene transfer to rat hepatocarcinomas by selective administration into the hepatic artery. Gene Ther 1998; 5: 896-904.
37. Albelda SM, Wiewrodt R, Sterman DH. Gene therapy for lung neoplasms. Clin Chest Med 2002; 23:265-277.
38. Cohen ZR, Duvdevani R, Nass D, Hadani M, Ram Z. Intraarterial delivery of genetic vectors for the treatment of malignant brain tumors. Isr Med Assoc J 2001; 3:117-120.
39. Biceroglu S, Memis A. Gene therapy: Applications in Interventional Radiology. Diagn Interv Radiol 2005; 11(2): 113-8.
40. Maher MM, Gervais DA, Kalra MK, Lucey B, Sahani DV, Arellano R, Hahn PF, Mueller PR. The inaccessible or undrainable abscess: How to drain it. Radiographics 2004; 24(3): 717-35.
41. Venbrux AC, Osterman FA. Malignant obstruction of the hepatobiliary system. In: Stanley Baum and Michael J Pentecost, editors.Abram's Angiography: Interventional Radiology. Boston, MA, USA. Little, Brown and Co. 1997: 472-482.
42. Burke DR, Lewis CA, Cardella JF, Citron SJ, Drooz AT, Haskal ZV et al, for the Society of Interventional Radiology Standards of Practice Committee. Quality improvement guidelines for percutaneous transhepatic cholangiography and biliary drainage. J Vasc Interv Radiol 2003; 14: S246-S246.
43. Rossi P, Bezzi M, Rossi M et al. Metal stents in malignant biliary obstruction: Results of a multicenter European study of 240 patients. J Vasc Interv Radiol 1994; 5: 279-285.
44. Becker CD, Giatti A, Malbach R, Bauer HU. Percutaneous obstructive jaundice with the Wallstent endoprosthesis: Follow-up and re-intervention in patients with hilar and non-hilar obstruction. J Vasc Interv Radiol 1993; 4: 597-604.
45. Carrasco CH, Zornoza J, Bechtel WJ. Malignant biliary obstruction: Complications of percutaneous biliary drainage. Radiology 1984; 152(2): 343-6.
46. Nomura T, Shirai Y, Hatakeyama K. Bacteribilia and cholangitis after percutaneous transhe-patic biliary drainage for malignant biliary obstruction. Dig Dis Sci 1999; 44(3): 542-6.
47. McNicholas MM, Lee MJ, Dawson SL, et al. Complications of percutaneous biliary drainage and stricture dilatation. Semin Interv Radiol 1994; 11: 242-253.
48. Ramchandani P, Cardella JF, Grassi CJ, Roberts AC, Sacks DSchwartzberg MS et al, for the Society of Interventional Radiology standards of practice committee. J Vasc Interv Radiol 2003; 14: S277-S281.
49. Lang EK, Price ET. Redefinitions of indications for percutaneous nephrostomy. Radiology 1983; 147: 419.
50. Watson GM, Patel U. Primary antegrade ureteral stenting: Prospective experience and cost effectiveness analysis in 50 ureters. Clin Radiol 2001; 56:568-574.
51. Yossepowitch O, Lifshitz DA, Dekel Y, et al. Predicting the success of retrograde stenting for managing ureteral obstruction. J Urol 2001; 166:1746-1749.
52. Tolley D. Ureteric stents, far from ideal. Lancet 2000; 356:872-873.
53. Wollman BS, Horacio BD, Walus-Wigle JR, Easter DW, Beale A. Radiologic, endoscopic, and surgical gastrostomy: An institutional evaluation and meta-analysis of the literature. Radiology 1995; 197: 699-704.
54. Goncalves F, Mozes M, Saraiva I, Ramos C. Gastrostomies in palliative care. Support Care Cancer 2006; 14(11): 1147-51.
55. Silas AM, Pearce LF, Lestina LS, Grove MR, Tosteson A, Manganiello WD, Bettmann MA, Gordon SR. Percutaneous radiologic gastrostomy versus percutaneous endoscopic gastros-tomy: A comparison of indications, complications and outcomes in 370 patients. Eur J Radiol 2005; 56(1): 84-90.
56. Ryan JM, Hahn PF, Mueller PR. Performing radiologic gastrostomy or gastrojejunostomy in patients with malignant ascites. AJR Am J Roentgenol 1998; 171(4): 1003-6.
57. Howard PH, Bonica JJ, Bergner M. The prevalence of pain in four cancers. Cancer 1987; 60: 2563 -2569
58. Ahmedzai S. New approaches to pain control in patients with cancer. Eur J Cancer 1997; 33 Suppl 6: S8-14.
59. McGraw JK, Cardella J, Barr JD, Mathis JM, Sanchez O, Schwartzberg MS, Swan TL, Sacks D et al, for the Society of Interventional Radiology Standards of Practice Committee. Society of Interventional Radiology quality improvement guidelines for percutaneous vertebroplasty. J Vasc Interv Radiol 2003; 14(9 Pt 2): S311-S315.
60. McGraw JK, Lippert JA, Minkus KD, Rami PM, Davis TM, Budzik RF. Prospective evaluation of pain relief in 100 patients undergoing percutaneous vertebroplasty: Results and follow-up. J Vasc Interv Radiol 2002; 13(9 Pt 1): 883-6.
61. Crandall D, Slaughter D, Hankins PJ, Moore C, Jerman J. Acute versus chronic vertebral compression fractures treated with kyphoplasty: Early results. Spine J 2004; 4(4): 418-24.
62. Titton RL, Lucey BC, Gervais DA, Boland GW, Mueller PR. Celiac plexus block: A palliative tool underused by Radiologists. Am J Roentgenol. 2002; 179(3): 633-6.
63. Akinci D, Akhan O. Celiac ganglia block. Eur J Radiol 2005; 55(3): 355-61.
64. Akhan O, Ozmen MN, Basgun N, Akinci D, Oguz O, Koroglu M, Karcaaltincaba M. Long-term results of celiac Ganglia block: Correlation of grade of tumoral invasion and pain relief. AJR Am J Roentgenol 2004; 182(4): 891-6.
65. England A, Tam CL, Thacker DE, Walker AL, Parkinson AS, Demello W, Bradley AJ, Tuck JS, Laasch HU, Butterfield JS, Ashleigh RJ, England RE, Martin DF. Patterns, incidence and predictive factors for pain after Interventional Radiology. Clin Radiol 2005; 60(11): 1188-94.
66. Shaw P, Agarwal R. Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev 2004; (1): CD002916.
67. Grassi CJ, Swan TL, Cardella JF, Meranze SG, Oglevie SB, Omary RA et al, for the Society of Interventional Radiologists Standards of Practice Committee. Quality improvement guidelines for percutaneous permanent inferior vena cava filter placement for the prevention of pulmonary embolism. J Vasc Interv Radiol 2003; 14: S271-S275.
68. Streiff MB. Vena caval filters: A review for intensive care specialists. J Intensive Care Med 2003; 18(2): 59-79.
69. Gervais DA, Brown SD, Connolly SA, Brec SL, Harisinghani MG, Mueller PR. Percutaneous imaging-guided abdominal and pelvic abscess drainage in children. Radiographics 2004; 24(3): 737-54.
70. Bakal CW, Sacks D, Burke DR, Cardella JF, Chopra PS, Dawson SL et al; Society of Interventional Radiology Standards of Practice Committee. Quality improvement guidelines for adult percutaneous abscess and fluid drainage. J Vasc Interv Radiol 2003; 14(9 Pt 2): S223-5.